Previous 10 | Next 10 |
home / stock / lxxgf / lxxgf news
BEVERLY, Mass., June 17, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) a molecular diagnostics company, is pleased to announce that today, Dr. Jack Regan, CEO and Founder of LexaGene, will present at the Biothreat and Pathogen Detection Co...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – June 15, 2021 – Dogs have always been man’s best friend, but the amount of money pet owners are shelling out for their four-legged friends has grown substantially over the years. ...
BEVERLY, Mass., June 14, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ), a molecular diagnostics company, announced the Company has sold another MiQLab ™ System and the CEO will present at multiple conferences. LexaGene CEO...
LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF) , a molecular diagnostics company that develops fully automated, rapid pathogen detection systems, today announced it has successfully utilized the MiQLab(TM) system to detect the presence of a slow-growing bacterium responsible for millions of ...
MiQLab detects 100% of C. acnes samples 36-times faster than a culture started from ideal laboratory conditions (in 2 hours versus 3 days) MiQLab can be as much as 168-times faster than a culture started from a bioreactor sample (2 hours versus 14 days) Adopting MiQLab...
MiQLab detects 100% of C. acnes samples 36-times faster than a culture started from ideal laboratory conditions (in 2 hours versus 3 days) MiQLab can be as much as 168-times faster than a culture started from a bioreactor sample (2 hours versus 14 days) Adopting MiQLab could...
LexaGene (TSX.V: LXG) (OTCQB: LXXGF) , a molecular diagnostics company that develops fully automated rapid pathogen detection systems, has received a purchase order for its exclusive MiQLab System(TM) from Denver Animal Emergency. The North Carolina emergency medicine and compassionate...
BEVERLY, Mass., June 07, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (the “ Company ”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce Denver Anima...
LexaGene Holdings (LXXGF) has partnered with Ethos Discovery to develop new companion animal diagnostic tests.The company's first validated panel, MiQLab Bacterial and AMR Test, was developed specifically for aiding in the diagnosis of urinary tract infections ((UTI)), one of the most co...
BEVERLY, Mass., June 03, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( TSX-V: LXG ; OTCQB: LXXGF ) (the “ Company ”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce it has partn...
News, Short Squeeze, Breakout and More Instantly...
Lexagene Holdings Company Name:
LXXGF Stock Symbol:
OTCMKTS Market:
BEVERLY, Mass., Feb. 24, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), announces that it has ceased operations, laid off its staff, and, together with its direct subsidiary LexaGene, Inc., and its indir...
BEVERLY, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“ LexaGene ” or the “ Company ”), a molecular diagnostics company that has commercialized the MiQLab™ System for automated mul...
BEVERLY, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab™ System for automate...